Avexis' $147M Follow-On Offering Leads 2 Biotech Stock Deals
Venture-backed Avexis completed a follow-on offering Thursday raising $146.6 million, which marks the gene therapy biotech's first return to public capital markets since a $95 million initial public offering in February,...To view the full article, register now.
Already a subscriber? Click here to view full article